Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma

Wang H, Naghavi M, Allen C, Barber RM, Carter A, Casey DC, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–544.

Article  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7–33.

PubMed  Article  Google Scholar 

Bruix J, Chan SL, Galle PR, Rimassa L, Sangro B. Systemic treatment of hepatocellular carcinoma: An EASL position paper. J Hepatol [Internet]. 2021; 75:960–74. Available from: https://www.sciencedirect.com/science/article/pii/S0168827821019036.

Duarte S, Baber J, Fujii T, Coito AJ. Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biol. 2015;44–46:147–56.

PubMed  Article  Google Scholar 

Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1–73.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161–74. https://doi.org/10.1038/nrc745.

CAS  Article  PubMed  Google Scholar 

Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol. 1996;3:895–904.

CAS  PubMed  Article  Google Scholar 

Masson R, Lefebvre O, Noël A, Fahime ME, Chenard MP, Wendling C, et al. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol. 1998;140:1535–41.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 1998;58:1048–51.

CAS  PubMed  Google Scholar 

Itoh T, Tanioka M, Matsuda H, Nishimoto H, Yoshioka T, Suzuki R, et al. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis. 1999;17:177–81.

CAS  PubMed  Article  Google Scholar 

Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 1999;98:137–46.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 2000;103:481–90.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, Lee TH, et al. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res. 2001;61:984–90.

CAS  PubMed  Google Scholar 

Wang S-W, Tai H-C, Tang C-H, Lin L-W, Lin T-H, Chang A-C, et al. Melatonin impedes prostate cancer metastasis by suppressing MMP-13 expression. J Cell Physiol. 2021;236:3979–90.

CAS  PubMed  Article  Google Scholar 

Azevedo Martins JM, Rabelo-Santos SH, do Amaral Westin MC, Zeferino LC. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis. BMC Cancer. 2020;20:660. https://doi.org/10.1186/s12885-020-07150-3.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Määttä M, Soini Y, Liakka A. Autio-Harmainen H. Differential Expression of Matrix Metalloproteinase (MMP)-2, MMP-9, and Membrane Type 1-MMP in Hepatocellular and Pancreatic Adenocarcinoma: Implications for Tumor Progression and Clinical Prognosis. Clin Cancer Res [Internet]. 2000; 6:2726 LP – 2734. Available from: http://clincancerres.aacrjournals.org/content/6/7/2726.abstract.

Yu J, Ma S, Tian S, Zhang M, Ding X, Liu Y, et al. Systematic construction and validation of a prognostic model for hepatocellular carcinoma based on immune-related genes. Front Cell Dev Biol. 2021;9:700553.

PubMed  PubMed Central  Article  Google Scholar 

Jacob A, Prekeris R. The regulation of MMP targeting to invadopodia during cancer metastasis. Front Cell Dev Biol. 2015;3:4.

PubMed  PubMed Central  Article  Google Scholar 

Sakamoto Y, Mafune K, Mori M, Shiraishi T, Imamura H, Mori M, et al. Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma. Int J Oncol. 2000;17:237–43.

CAS  PubMed  Google Scholar 

Cao W, Fan W, Wang F, Zhang Y, Wu G, Shi X, et al. GM-CSF impairs erythropoiesis by disrupting erythroblastic island formation via macrophages. J Transl Med. 2022;20(1):1–7.

Article  Google Scholar 

Wang Y, Li W, Schulz VP, Zhao H, Qu X, Qi Q, et al. Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiency. Blood Internet. 2021;1(138):1615–27. https://doi.org/10.1182/blood.2020007401/476012/Impairment-of-human-terminal-erythroid.

Article  Google Scholar 

Li W, Wang Y, Zhao H, Zhang H, Xu Y, Wang S, et al. Identification and transcriptome analysis of erythroblastic island macrophages. Blood Am Soc Hematol. 2019;134:480–91.

CAS  Google Scholar 

Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. Omi A J Integr Biol. 2012;10801(16):284–7.

Article  Google Scholar 

Li B, Severson E, Pignon J-C, Zhao H, Li T, Novak J, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016;17:174.

PubMed  PubMed Central  Article  Google Scholar 

Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Sturm G, Finotello F, Petitprez F, Zhang JD, Baumbach J, Fridman WH, et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics. 2019;35:i436–45.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhou T, Cai Z, Ma N, Xie W, Gao C, Huang M, et al. A novel ten-gene signature predicting prognosis in hepatocellular carcinoma. Front cell Dev Biol. 2020;8:629.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lin W, Wu S, Chen X, Ye Y, Weng Y, Pan Y, et al. Characterization of hypoxia signature to evaluate the tumor immune microenvironment and predict prognosis in glioma groups. Front Oncol. 2020;10:796.

PubMed  PubMed Central  Article  Google Scholar 

Li W, Li T, Sun C, Du Y, Chen L, Du C, et al. Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients. Mol Med. 2022;28:43. https://doi.org/10.1186/s10020-022-00467-8.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Xiong Y, Yuan L, Xiong J, Xu H, Luo Y, Wang G, et al. An outcome model for human bladder cancer: a comprehensive study based on weighted gene co-expression network analysis. J Cell Mol Med. 2020;24:2342–55.

CAS  PubMed  Article  Google Scholar 

Jeong S-H, Kim RB, Park SY, Park J, Jung E-J, Ju Y-T, et al. Nomogram for predicting gastric cancer recurrence using biomarker gene expression. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2020;46:195–201.

Google Scholar 

Liu Z, Mi M, Li X, Zheng X, Wu G, Zhang L. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer. J Cell Mol Med. 2020;24:12444–56.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014;158:929–44.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Iglesia MD, Parker JS, Hoadley KA, Serody JS, Perou CM, Vincent BG. Genomic analysis of immune cell infiltrates across 11 tumor types. J Natl Cancer Inst. 2016. https://doi.org/10.1093/jnci/djw144.

Article  PubMed  PubMed Central  Google Scholar 

Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173:338-354.e15.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Van den Eynden GG, Majeed AW, Illemann M, Vermeulen PB, Bird NC, Høyer-Hansen G, et al. The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications. Cancer Res [Internet]. 2013; 73:2031 LP – 2043. Available from: http://cancerres.aacrjournals.org/content/73/7/2031.abstract.

Hu B, Jarzynka MJ, Guo P, Imanishi Y, Schlaepfer DD, Cheng S-Y. Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the αvβ1 integrin and focal adhesion kinase signaling pathway. Cancer Res [Internet]. Am Assoc Cancer Res. 2006; 66:775–83. Available from: https://cancerres.aacrjournals.org/content/66/2/775.

Eke I, Cordes N. Focal adhesion signaling and therapy resistance in cancer. Semin Cancer Biol. 2015;31:65–75.

CAS  PubMed  Article  Google Scholar 

Shi B, Chu J, Huang T, Wang X, Li Q, Gao Q, et al. The scavenger receptor MARCO expressed by tumor-associated macrophages are highly associated with poor pancreatic cancer prognosis. Front Oncol. 2021;11:771488.

PubMed  PubMed Central  Article  Google Scholar 

Pinter M, Scheiner B, Peck-Radosavljevic M. Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups. Gut. 2021;70:204–14.

CAS 

留言 (0)

沒有登入
gif